Overall, these results suggested that antiinflammatory agents lower CFTR expression, CFTR modulator–induced anion secretion, and/or ASL alkalinization in TNF-α+IL-17–treated CF epithelia. The gene discussed is CFTR; the disease is cystic fibrosis.